Sun Pharma Advanced Research Company Ltd. (SPARC)
Market Open
11 Aug, 10:00
XNSE XNSE Primary MSE ₹
210. 03
+2.71
+1.3072%
₹
42.66B Market Cap
- P/E Ratio
- Div Yield
166,757 Volume
0 Eps
₹ 207.32
Previous Close Want to track SPARC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sun Pharma Advanced Research Company Ltd. (SPARC) Statistics
Valuation metrics
Market Cap 42.66B
Enterprise value 74.77B
Trailing P/E (ttm) 4.46
Forward P/E 2.37
PEG ratio 0.01
Price/Sales (ttm) 3.68
Price/Book (mrq) 5.17
Enterprise Value/Revenue 3.98
Enterprise Value/EBITDA 4.69
Overview
Shares outstanding 324.52M
Float 91.32M
Shares short -
% Held by insiders 0.73%
% Held by institutions 0.03%
Average volume (10 days) 1.01M
Average volume (90 days) 5.37M
Price summary
52-Week low 108
52-Week high 289
Beta 0.11
50-Day moving average 232.76
200-Day moving average 173.19
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 127:125
Last split Date 23 Aug 2012
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.83%
Operating margin 0.85%
Operational effectiveness
Return on assets 0.72%
Return on equity 14.36%
Income Statement
Revenue (ttm) 531.36M
Revenue per share (ttm) 57.9
Quarterly revenue growth (yoy) -0.43%
Gross profit (ttm) 219.16M
EBITDA -2.28B
Net income to common (ttm) -2.68B
Diluted EPS (ttm) 47.86
Quarterly earnings growth (yoy) -0.43%
Balance Sheet
Total cash (mrq) 9.4M
Total cash per share (mrq) 0.08
Total debt (mrq) 4.17B
Total Debt/Equity (mrq) 0.42
Current ratio (mrq) 2.47%
Book value per share (mrq) 41.25
Cash Flow
Cash flow statement -3.48B
Levered free cash flow (LFCF) -3.43B
